Bumper Offer - Urjas oil Just @ Rs. 1
Opel (Gufic) is a prescription drug, available for use as Capsule. It is typically used for the treatment of Acidity, Peptic Ulcer, GERD. Secondary and off-label uses of Opel (Gufic) have also been mentioned below.
The optimal dosage of Opel (Gufic) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Opel (Gufic) as well, which are listed below. Such side effects of Opel (Gufic) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Opel (Gufic) has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Opel (Gufic) related warnings talks about Opel (Gufic)'s effects on the liver, heart and kidney.
Some other conditions that can be affected by Opel (Gufic) are listed in the contraindications section below.
Besides this, Opel (Gufic) may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Opel (Gufic), it is important to know that it is not safe while driving, and is not habit-forming.
Opel (Gufic) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Opel (Gufic) is used -
Severe
Moderate
Mild
Is the use of Opel (Gufic) safe for pregnant women?
Opel (Gufic) rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Opel (Gufic) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Opel (Gufic). Immediately discontinue Opel (Gufic) if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Opel (Gufic) on the Kidneys?
Opel (Gufic) has very mild side effects on the kidneys.
What is the effect of Opel (Gufic) on the Liver?
Opel (Gufic) has very mild side effects on the liver.
What is the effect of Opel (Gufic) on the Heart?
Side effects of Opel (Gufic) rarely affect the heart.
Opel (Gufic) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Opel (Gufic) unless your doctor advises you to do so -
Is this Opel (Gufic) habit forming or addictive?
Opel (Gufic) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Opel (Gufic) as you may feel sleepy.
Is it safe?
Yes, Opel (Gufic) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Opel (Gufic) for mental disorders.
Interaction between Food and Opel (Gufic)
Taking Opel (Gufic) with food does not harm your health.
Interaction between Alcohol and Opel (Gufic)
Taking Opel (Gufic) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prilosec (omeprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 651-653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 945-947
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prilosec (omeprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 651-653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 945-947
